Welcome to our dedicated page for Amentum Holdings SEC filings (Ticker: AMTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amentum Holdings, Inc. (NYSE: AMTM) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents are a primary source of information on Amentum’s financial performance, governance, risk factors and executive compensation as an advanced engineering and technology company serving U.S. and allied government markets.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed discussions of segment performance in Digital Solutions and Global Engineering Solutions, contract backlog, cash flow, and other key metrics. Earnings-related Form 8-K filings, such as those furnished in connection with fiscal year 2025 and interim quarters, include press releases that summarize results and outline factors driving revenue and adjusted EBITDA across Amentum’s government-focused programs.
The company’s DEF 14A definitive proxy statement provides extensive information on corporate governance, the composition and responsibilities of the board of directors, committee structures, and compensation programs for named executive officers. It also describes matters submitted to stockholders at the annual meeting, including director elections, ratification of the independent registered public accounting firm and the advisory vote on executive compensation.
Through this page, users can also monitor other current reports and, where applicable, insider-related filings such as Forms 3, 4 and 5 that disclose transactions by directors and officers. Stock Titan enhances these filings with AI-powered summaries that highlight key points, explain complex sections in plain language and help readers quickly identify items such as changes in guidance, notable contract developments, or governance updates.
Filings are updated in near real time as they appear on the SEC’s EDGAR system, allowing investors, analysts and other stakeholders to follow Amentum’s regulatory history, understand the drivers of its space, defense, nuclear and digital infrastructure work, and assess how governance and compensation practices align with disclosed performance.
Invesco Ltd. filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 22,116,835 shares of Amentum Holdings Inc. common stock, representing 9.1% of the class. Invesco reports sole voting power over 22,069,274 shares and sole dispositive power over 22,116,835 shares, with no shared voting or dispositive power. The event date is 09/30/2025. Invesco states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Amentum Holdings, Inc. (AMTM) S-3ASR prospectus describes the incorporation by reference of prior SEC filings, identifies selling stockholders and the methods by which registered shares may be sold, and summarizes shareholder rights and corporate governance provisions. The prospectus incorporates quarterly reports, audited and unaudited financial statements for certain business units acquired from Jacobs, the 2025 proxy’s Part III disclosures, and an updated description of capital stock from the company’s 10-K. It discloses that authorized capital includes 1,000,000,000 shares of Common Stock and 1,000,000 shares of preferred stock, explains voting, dividend and liquidation rights for common shares, and notes the Board’s authority to issue preferred stock with varying rights. The document details selling stockholder registration mechanics, potential sale methods, FATCA and U.S. federal tax rules applicable to Non-U.S. Holders, anti-takeover provisions, and indemnification and limitation of liability provisions for directors and officers.
Q3 FY2025 highlights: Amentum reported three-month revenues of $3,561 million (vs. $2,142 million prior-year) and nine-month revenues of $10,468 million (vs. $6,176 million prior-year), driven by the merger with Jacobs CMS. GAAP net income attributable to common shareholders was $10 million for the quarter and $26 million for the nine months; basic diluted EPS were $0.04 and $0.11, respectively. Cash and cash equivalents were $738 million and total assets were $11,808 million. Total debt, net of OID and fees, was $4,484 million.
Material transactions and metrics: CMS acquisition consideration totaled $4,032 million with preliminary purchase price allocations and measurement-period adjustments; goodwill totaled $5,616 million at June 27, 2025. The company completed the sale of Rapid Solutions for $360 million. Remaining performance obligations were $9.5 billion, with ~73% expected in the next 12 months. Significant amortization expense was $118 million for the quarter and the effective tax rate was 108.3% for the three months ended June 27, 2025.